GEL-ONE(R)

Acid, Hyaluronic, Intraarticular

FDA Premarket Approval P080020 S020

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for gel-one. The device is indicated for the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (nsaids) or analgesics, e. G. , acetaminophen.

DeviceGEL-ONE(R)
Classification NameAcid, Hyaluronic, Intraarticular
Generic NameAcid, Hyaluronic, Intraarticular
ApplicantSEIKAGAKU CORP.
Date Received2016-04-01
Decision Date2016-09-27
Notice Date2016-09-30
PMAP080020
SupplementS020
Product CodeMOZ
Docket Number16M-2975
Advisory CommitteeOrthopedic
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address SEIKAGAKU CORP. 6-1, Marunouchi 1-chome, chiyoda-ku tokyo 100-0-0005
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P080020Original Filing
S051 2022-12-08 30-day Notice
S050
S049 2022-09-20 30-day Notice
S048 2022-06-22 30-day Notice
S047 2022-03-03 30-day Notice
S046 2021-10-27 30-day Notice
S045 2021-09-15 30-day Notice
S044 2021-07-22 30-day Notice
S043 2021-04-29 30-day Notice
S042 2021-03-18 30-day Notice
S041
S040 2020-10-20 30-day Notice
S039 2020-10-14 30-day Notice
S038 2020-07-01 30-day Notice
S037 2020-03-10 30-day Notice
S036 2020-02-25 30-day Notice
S035 2019-08-01 Real-time Process
S034
S033 2019-02-07 30-day Notice
S032 2019-02-05 30-day Notice
S031 2018-11-07 30-day Notice
S030 2018-07-12 30-day Notice
S029 2018-02-14 30-day Notice
S028 2018-01-10 30-day Notice
S027 2017-11-15 30-day Notice
S026 2017-06-28 135 Review Track For 30-day Notice
S025 2017-02-23 30-day Notice
S024 2016-12-22 30-day Notice
S023 2016-11-22 30-day Notice
S022 2016-11-01 30-day Notice
S021 2016-06-30 30-day Notice
S020 2016-04-01 Panel Track
S019 2016-02-24 30-day Notice
S018 2015-08-31 Normal 180 Day Track
S017 2015-07-30 30-day Notice
S016 2015-07-29 30-day Notice
S015 2015-06-16 30-day Notice
S014 2015-05-05 Normal 180 Day Track
S013 2014-09-30 30-day Notice
S012 2014-07-31 30-day Notice
S011 2014-07-30 30-day Notice
S010 2014-07-29 30-day Notice
S009 2014-07-28 30-day Notice
S008 2014-06-17 135 Review Track For 30-day Notice
S007 2014-05-01 30-day Notice
S006 2013-09-13 30-day Notice
S005 2013-07-25 30-day Notice
S004 2012-11-02 30-day Notice
S003 2012-10-04 30-day Notice
S002 2012-05-01 135 Review Track For 30-day Notice
S001 2012-04-04 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00087541300912 P080020 012
04987541300911 P080020 012

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.